Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9-12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
在菲律宾,一项非劣效性4期随机临床试验研究了同时或序贯接种减毒活疫苗SA 14-14-2日本脑炎疫苗(CD-JEV)和麻疹-腮腺炎-风疹疫苗对9-12月龄婴儿的免疫原性和安全性。
期刊:Vaccine: X
影响因子:2.2
doi:10.1016/j.jvacx.2020.100074
Capeding, Maria Rosario; Alberto, Edison; Feser, Jodi; Mooney, Jessica; Tang, Yuxiao; Audet, Susette A; Beeler, Judy A; Ellison, Damon W; Zhang, Lei; Letson, G William; Neuzil, Kathleen M; Marfin, Anthony A